0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > TRBC1

TRBC1

Brief Information

Name:TRBC1
Target Synonym:T cell receptor beta constant 1,TRBC1,V_segment Translation Product,BV05S1J2.2,TCRBC1,TCRB
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Por estado del producto :
Por categoría de producto :
Por especies :
Cat. No. Especies Descripción del producto Estructura Pureza Característica
TR1-H82E6 Human Biotinylated Human TRBC1 Protein, His,Avitag™
TR1-H82E6-structure
TR1-H82E6-sds
TR1-H52H4 Human Human TRBC1 Protein, His Tag (HPLC verified)
TR1-H52H4-structure
TR1-H52H4-sds
TR1-H52H4-hplc
ACRO Quality

Customer Reviews

Synonym Name

T cell receptor beta constant 1,TRBC1

Background

The transmembrane protein, TCR, comprise of two disulphide-linked polypeptide chains: a α and β chain, a γ and δ chain. Each polypeptide chain consists of a variable and a constant region. TRBC1 is the constant region of T-cell receptor (TCR) beta chain.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
AUTO-4 (Autolus) AUTO-4 Phase 2 Clinical University College London Lymphoma, T-Cell, Peripheral; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell Details
STAR-0602 STAR-0602 Phase 2 Clinical Marengo Therapeutics Inc Solid tumours; Carcinoma; Abdominal Neoplasms; Papillomavirus Infections; Neoplasms; Vulvar Neoplasms; Urogenital Neoplasms; Lung Neoplasms; Epstein-Barr Virus Infections; Vulvar Diseases Details
CAR-T Cell Therapy (Persongen Biotherapeutics) Phase 1 Clinical Persongen Biotherapeutics (Suzhou) Co Ltd Neoplasms Details
Anti-TRBC1 CAR-T cell therapy (Shanghai General Hospital) Phase 1 Clinical Shanghai General Hospital Hematologic Neoplasms Details
FT-819 FT-8198; FT-819; FT 8198 Phase 1 Clinical Memorial Sloan Kettering Cancer Center Lymphoma, B-Cell; Lupus Erythematosus, Systemic; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell Details
AUTO-4 (Autolus) AUTO-4 Phase 2 Clinical University College London Lymphoma, T-Cell, Peripheral; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell Details
STAR-0602 STAR-0602 Phase 2 Clinical Marengo Therapeutics Inc Solid tumours; Carcinoma; Abdominal Neoplasms; Papillomavirus Infections; Neoplasms; Vulvar Neoplasms; Urogenital Neoplasms; Lung Neoplasms; Epstein-Barr Virus Infections; Vulvar Diseases Details
CAR-T Cell Therapy (Persongen Biotherapeutics) Phase 1 Clinical Persongen Biotherapeutics (Suzhou) Co Ltd Neoplasms Details
Anti-TRBC1 CAR-T cell therapy (Shanghai General Hospital) Phase 1 Clinical Shanghai General Hospital Hematologic Neoplasms Details
FT-819 FT-8198; FT-819; FT 8198 Phase 1 Clinical Memorial Sloan Kettering Cancer Center Lymphoma, B-Cell; Lupus Erythematosus, Systemic; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell Details

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje